UPSIDE Foods, a Berkeley, California-based company that grows meat, poultry and seafood directly from animal cells, becomes the first in the world to receive approval from the U.S. Food and Drug Administration for its lab-grown meat. The FDA said that its meat product is safe for human consumption.
According to Reuters, this is the first time that the U.S. FDA has granted such approval for cultivated meat. The US agency revealed its decision on Wednesday this week. UPSIDE Foods made chicken meat by collecting cells from live animals and using them to cultivate meat inside stainless steel tanks.
With the FDA’s approval, the company may continue with its plans to sell its products. However, in a joint statement, Robert M. Califf, M.D., the commissioner of Food and Drugs - Food and Drug Administration and Susan T. Mayne, Ph.D., the director of Center for Food Safety and Applied Nutrition (CFSAN), said that before UPSIDE Foods can fully proceed with marketing the cell-cultured meat, an inspection from the U.S. Department of Agriculture (USDA) and USDA-Food Safety and Inspection Service (FSIS) are still needed.
At any rate, the American food and drug regulator further said that it had already analyzed data from UPSIDE Foods, and it has no further questions about its conclusion that the lab-grown meat is safe to eat. But then again, the FDA explained that its review is not technically an approval and pointed out that it is only for UPSIDE products and does not apply to other companies in the same business.
"This is a watershed moment in the history of food and we started UPSIDE amid a world full of skeptics, and today, we've made history again as the first company to receive a 'No Questions' letter from the FDA for cultivated meat,” UPSIDE Foods’ founder and chief executive officer, Dr. Uma Valeti, said in a press release.
The CEO added, “This milestone marks a major step towards a new era in meat production, and I'm thrilled that U.S. consumers will soon have the chance to eat delicious meat that's grown directly from animal cells."


UK Housebuilder Stocks Surge on New First-Time Buyer Loan Scheme
U.S. Stock Futures Steady as AI, Rate Concerns Weigh
Bitget Restores Withdrawals After $388 Million Security Breach
Stellar Hits Record 217 TPS as Institutional RWA Activity Surges
Samsung Invests $1 Billion in KKR’s Helix AI Infrastructure
OpenAI Scraps GPT-6.1 Astra Launch Over Safety Concerns
South Korea Exports Set for 16th Monthly Gain on AI Chip Demand
Goldman Sachs Eyes John Waldron as CEO Successor
Asian Currencies Mixed as Yen Weakens, RBA Hike Looms
Anthropic Targets $2 Trillion Valuation in Planned IPO
South Korea Tax Windfall Could Top 50 Trillion Won on Chip Boom
Gold Slides Below $4,300 as Oil Surge Fuels Fed Rate Hike Bets
RBA Set for September Rate Hike as Inflation Stays High
RedotPay Completes Audits as Stablecoin Firm Advances U.S. IPO Plans
Citigroup Expands Coinbase Partnership for Stablecoin Payments
Nvidia China Chip Sales Report Sends Chinese Semiconductor Stocks Lower
Toyota Global Sales Fall for Seventh Month as China Demand Slumps 



